SIRT3 and cholangiocarcinoma: Use of metabolic inhibitors can induce tumor cell death by elevating the intracellular ROS levels.47 In present study, we demonstrated that SIRT3 inhibited CCA proliferation by inhibiting glycolysis and enhancing mitochondrial metabolism.